These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23308058)

  • 1. p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
    Al-Ansari MM; Hendrayani SF; Tulbah A; Al-Tweigeri T; Shehata AI; Aboussekhra A
    Neoplasia; 2012 Dec; 14(12):1269-77. PubMed ID: 23308058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
    Al-Ansari MM; Hendrayani SF; Shehata AI; Aboussekhra A
    Oncogene; 2013 May; 32(18):2356-64. PubMed ID: 22751126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts.
    Al-Ansari MM; Aboussekhra A
    Oncotarget; 2015 Oct; 6(30):30006-16. PubMed ID: 26338965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects.
    Hendrayani SF; Al-Khalaf HH; Aboussekhra A
    Neoplasia; 2013 Jun; 15(6):631-40. PubMed ID: 23730211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells.
    Zhang J; Lu A; Li L; Yue J; Lu Y
    Cancer Invest; 2010 Jul; 28(6):588-97. PubMed ID: 20307196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.
    Tang X; Zhang Q; Shi S; Yen Y; Li X; Zhang Y; Zhou K; Le AD
    Int J Cancer; 2010 Jan; 126(1):90-103. PubMed ID: 19569175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
    Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
    Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
    Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.
    Hendrayani SF; Al-Khalaf HH; Aboussekhra A
    J Biol Chem; 2014 Nov; 289(45):30962-76. PubMed ID: 25231991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.
    Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L
    Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth.
    Zhang E; Shi H; Yang L; Wu X; Wang Z
    Oncol Rep; 2017 Jul; 38(1):359-367. PubMed ID: 28534996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
    Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
    PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
    Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
    Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and p16
    Al-Khalaf HH; Amir M; Al-Mohanna F; Tulbah A; Al-Sayed A; Aboussekhra A
    Mol Cell Biol; 2017 Sep; 37(17):. PubMed ID: 28630279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines.
    Box AH; Demetrick DJ
    Carcinogenesis; 2004 Dec; 25(12):2325-35. PubMed ID: 15347600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.